KPIs & Operating Metrics(New)
Growth Metrics

Charles River Laboratories International (CRL) Change in Accured Expenses (2016 - 2025)

Charles River Laboratories International has reported Change in Accured Expenses over the past 17 years, most recently at -$2.6 million for Q4 2025.

  • For Q4 2025, Change in Accured Expenses rose 90.0% year-over-year to -$2.6 million; the TTM value through Dec 2025 reached $79.3 million, up 387.31%, while the annual FY2025 figure was $79.3 million, 387.31% up from the prior year.
  • Change in Accured Expenses for Q4 2025 was -$2.6 million at Charles River Laboratories International, down from $42.9 million in the prior quarter.
  • Over five years, Change in Accured Expenses peaked at $51.3 million in Q2 2021 and troughed at -$79.8 million in Q1 2022.
  • A 5-year average of $3.3 million and a median of $4.9 million in 2021 define the central range for Change in Accured Expenses.
  • Biggest five-year swings in Change in Accured Expenses: surged 563.47% in 2023 and later plummeted 188.33% in 2024.
  • Year by year, Change in Accured Expenses stood at $26.1 million in 2021, then tumbled by 136.14% to -$9.4 million in 2022, then tumbled by 69.58% to -$16.0 million in 2023, then plummeted by 60.23% to -$25.6 million in 2024, then skyrocketed by 90.0% to -$2.6 million in 2025.
  • Business Quant data shows Change in Accured Expenses for CRL at -$2.6 million in Q4 2025, $42.9 million in Q3 2025, and $23.7 million in Q2 2025.